miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma

Tumour Biol. 2016 Jul;37(7):9001-7. doi: 10.1007/s13277-015-4578-5. Epub 2016 Jan 13.

Abstract

MicroRNAs (miRNAs) are a new class of prognostic and diagnostic biomarkers for many cancers. Recent studies have shown that miRNAs are highly stable in plasma/serum. The aim of this study was to investigate the role of miR-421 in osteosarcoma. We found that the serum expression levels of miR-421 were significantly higher in osteosarcoma patients than those in healthy volunteers. Moreover, miR-421 expression was significantly higher in osteosarcoma tissues compared with that in the adjacent normal tissues. Meanwhile, the expression of miR-421 was upregulated in 90 % (36/40) osteosarcoma tissues compared to non-tumor tissues. More importantly, the expression levels of miR-421 in osteosarcoma tissues were correlated with those in patients' serum. In addition, patients with high miR-421 expression had shorter overall survival (OS) than those with low expressions. We also found that overexpression of miR-421 promoted osteosarcoma cell line MG-63 proliferation, migration, and invasion. In conclusion, miR-421 expression levels were upregulated in osteosarcoma tissue and serum and it may be a useful marker for diagnosis of osteosarcoma.

Keywords: Invasion; MicroRNAs; Osteosarcoma; Serum miRNA; miR-421.

MeSH terms

  • Biomarkers, Tumor / blood*
  • Bone Neoplasms / blood*
  • Bone Neoplasms / diagnosis*
  • Bone Neoplasms / genetics
  • Case-Control Studies
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cell Proliferation / genetics
  • Gene Expression Regulation, Neoplastic / genetics
  • Humans
  • MicroRNAs / blood*
  • MicroRNAs / genetics
  • Neoplasm Invasiveness / genetics
  • Osteosarcoma / blood*
  • Osteosarcoma / diagnosis*
  • Osteosarcoma / genetics
  • Prognosis
  • Up-Regulation / genetics

Substances

  • Biomarkers, Tumor
  • MIRN421 microRNA, human
  • MicroRNAs